Export 48 results:
Author [ Title(Desc)] Type Year
Filters: First Letter Of Last Name is I  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
Hwang WYk, Takahashi S, Choi B, Huang H, Kawamata S, Ng SChin, Gupta P, Hamidieh AAli, Koaykul C, Irawan C, Srivastava A.  2024.  Challenges in Global Access to CAR-T cells: an Asian Perspective.. Blood Cell Ther. 7(1):10-13. DOI:10.31547/bct-2023-023.
Sivaraman G, Iniya M, Anand T, Kotla NG, Sunnapu O, Singaravadivel S, Gulyani A, Chellappa D.  2018.  Chemically diverse small molecule fluorescent chemosensors for copper ion. Coordination Chemistry Reviews. 357:50-104. DOI:https://doi.org/10.1016/j.ccr.2017.11.020.
Illangeswaran RStephen St, Jebanesan DZechariah, Sivakumar KKanimozhi, Vidhyadharan RThalayattu, Rajamani BM, Janet NBeryl, David E, Velayudhan SRamachandr, Mathews V, Balasubramanian P.  2023.  Chemotherapeutic drugs elicit stemness and metabolic alteration to mediate acquired drug-resistant phenotype in acute myeloid leukemia cell lines.. Leuk Res. 128:107054. DOI:10.1016/j.leukres.2023.107054.
Nath A, Rayabaram J, Ijee S, Bagchi A, Chaudhury ADutta, Roy D, Chambayil K, Singh J, Nakamura Y, Velayudhan SR.  2021.  Comprehensive Analysis of microRNAs in Human Adult Erythropoiesis.. Cells. 10(11) DOI:10.3390/cells10113018.
Illangeswaran RStephen St, Jebanesan DZechariah, Sivakumar KKanimozhi, Vidhyadharan RThalayattu, Rajamani BM, Janet NBeryl, David E, Velayudhan SRamachandr, Mathews V, Balasubramanian P.  2023.  Corrigendum to "Chemotherapeutic drugs elicit stemness and metabolic alteration to mediate acquired drug-resistant phenotype in acute myeloid leukemia cell lines" [Leukemia Res. 128, 107054].. Leuk Res. 130:107329. DOI:10.1016/j.leukres.2023.107329.
Sreeraj VS, Puzhakkal JC, Holla B, Nadella RKumar, Sheth S, Balachander S, Ithal D, Ali F, Viswanath B, Muralidharan K, Venkatasubramanian G, John JP, Benegal V, Murthy P, Varghese M, Reddy YJanardhan, Jain S.  2021.  Cross-diagnostic evaluation of minor physical anomalies in psychiatric disorders.. J Psychiatr Res. 142:54-62. DOI:10.1016/j.jpsychires.2021.07.028.
Venugopala KN, Chandrashekharappa S, Tratrat C, Deb PKishore, Nagdeve RD, Nayak SK, Morsy MA, Borah P, Mahomoodally FM, Mailavaram RPrasad, Attimarad M, Aldhubiab BE, Sreeharsha N, Nair AB, Alwassil OI, Haroun M, Mohanlall V, Shinu P, Venugopala R, Kandeel M et al..  2021.  Crystallography, Molecular Modeling, and COX-2 Inhibition Studies on Indolizine Derivatives.. Molecules. 26(12) DOI:10.3390/molecules26123550.
G
Prakash A, Kamat K, Inamdar MS.  2023.  Generation of an OCIAD2 overexpressing transgenic human embryonic stem cell line, BJNhem20-OCIAD2-OV.. Stem Cell Res. 67:103027. DOI:10.1016/j.scr.2023.103027.
Kamat K, Inamdar MS.  2023.  Generation of OCIAD2 homozygous knockout (BJNhem20-OCIAD2-CRISPR-33) and heterozygous knockout (BJNhem20-OCIAD2-CRISPR-40) human embryonic stem cell lines using CRISPR-Cas9 mediated targeting.. Stem Cell Res. 67:103026. DOI:10.1016/j.scr.2023.103026.
Nandakumar M, Ishtiaq F.  2020.  Genetic drift and bottleneck do not influence diversity in Toll-like receptor genes at a small spatial scale in a Himalayan passerine.. Ecol Evol. 10(21):12246-12263. DOI:10.1002/ece3.6855.
Dhar MS, Marwal R, Vs R, Ponnusamy K, Jolly B, Bhoyar RC, Sardana V, Naushin S, Rophina M, Mellan TA, Mishra S, Whittaker C, Fatihi S, Datta M, Singh P, Sharma U, Ujjainiya R, Bhatheja N, Divakar MKumar, Singh MK et al..  2021.  Genomic characterization and epidemiology of an emerging SARS-CoV-2 variant in Delhi, India.. Science. :eabj9932. DOI:10.1126/science.abj9932.
Dhar MS, Marwal R, Vs R, Ponnusamy K, Jolly B, Bhoyar RC, Sardana V, Naushin S, Rophina M, Mellan TA, Mishra S, Whittaker C, Fatihi S, Datta M, Singh P, Sharma U, Ujjainiya R, Bhatheja N, Divakar MKumar, Singh MK et al..  2021.  Genomic characterization and epidemiology of an emerging SARS-CoV-2 variant in Delhi, India.. Science. :eabj9932. DOI:10.1126/science.abj9932.
I
Anstey NJ, Kapgal V, Tiwari S, Watson TC, Toft AKH, Dando OR, Inkpen FH, Baxter PS, Kozić Z, Jackson AD, He X, Nawaz MSarfaraz, Kayenaat A, Bhattacharya A, Wyllie DJA, Chattarji S, Wood ER, Hardt O, Kind PC.  2022.  Imbalance of flight-freeze responses and their cellular correlates in the Nlgn3 rat model of autism.. Mol Autism. 13(1):34. DOI:10.1186/s13229-022-00511-8.
Benjamin ESathya Bam, Vinod E, Illangeswaran RStephen St, Rajamani BM, Vidhyadharan RThalayattu, Bagchi A, Maity A, Mohan A, Parasuraman G, Amirtham SManickam, Abraham A, Velayudhan SR, Balasubramanian P.  2024.  Immortalised chronic myeloid leukemia (CML) derived mesenchymal stromal cells (MSCs) line retains the immunomodulatory and chemoprotective properties of CML patient-derived MSCs.. Cell Signal. 116:111067. DOI:10.1016/j.cellsig.2024.111067.
Asokan MS, Joan RFlorina, Babji S, Dayma G, Nadukkandy P, Subrahmanyam V, Pandey A, Malagi G, Arya P, Mahajan V, Bhavikatti J, Pawar K, Thorat A, Shah P, Goud RB, Roy B, Rajukutty S, Immanuel S, Agarwal D, Saha S et al..  2024.  Immunogenicity of SARS-CoV-2 vaccines BBV152 (COVAXIN®) and ChAdOx1 nCoV-19 (COVISHIELD™) in seronegative and seropositive individuals in India: a multicentre, nonrandomised observational study.. Lancet Reg Health Southeast Asia. 22:100361. DOI:10.1016/j.lansea.2024.100361.
Asokan MS, Joan RFlorina, Babji S, Dayma G, Nadukkandy P, Subrahmanyam V, Pandey A, Malagi G, Arya P, Mahajan V, Bhavikatti J, Pawar K, Thorat A, Shah P, Goud RB, Roy B, Rajukutty S, Immanuel S, Agarwal D, Saha S et al..  2024.  Immunogenicity of SARS-CoV-2 vaccines BBV152 (COVAXIN®) and ChAdOx1 nCoV-19 (COVISHIELD™) in seronegative and seropositive individuals in India: a multicentre, nonrandomised observational study.. Lancet Reg Health Southeast Asia. 22:100361. DOI:10.1016/j.lansea.2024.100361.
Jebanesan DZechariah, Illangeswaran RStephen St, Rajamani BM, Vidhyadharan RThalayattu, Das S, Bijukumar NK, Balakrishnan B, Mathews V, Velayudhan SR, Balasubramanian P.  2024.  Inhibition of NRF2 signaling overcomes acquired resistance to arsenic trioxide in FLT3-mutated Acute Myeloid Leukemia.. Ann Hematol. 103(6):1919-1929. DOI:10.1007/s00277-024-05742-8.
Ikonomou L, Cuende N, Forte M, Grilley BJ, Levine AD, Munsie M, Rasko JEJ, Turner L, Bidkhori HR, Ciccocioppo R, Grignon F, Srivastava A, Weiss DJ, Zettler P, Levine BL.  2023.  International Society for Cell & Gene Therapy Position Paper: Key considerations to support evidence-based cell and gene therapies and oppose marketing of unproven products.. Cytotherapy. 25(9):920-929. DOI:10.1016/j.jcyt.2023.03.002.
Ikonomou L, Cuende N, Forte M, Grilley BJ, Levine AD, Munsie M, Rasko JEJ, Turner L, Bidkhori HR, Ciccocioppo R, Grignon F, Srivastava A, Weiss DJ, Zettler P, Levine BL.  2023.  International Society for Cell & Gene Therapy Position Paper: Key considerations to support evidence-based cell and gene therapies and oppose marketing of unproven products.. Cytotherapy. 25(9):920-929. DOI:10.1016/j.jcyt.2023.03.002.
Ludwig TE, Andrews PW, Barbaric I, Benvenisty N, Bhattacharyya A, Crook JM, Daheron LM, Draper JS, Healy LE, Huch M, Inamdar MS, Jensen KB, Kurtz A, Lancaster MA, Liberali P, Lutolf MP, Mummery CL, Pera MF, Sato Y, Shimasaki N et al..  2023.  ISSCR standards for the use of human stem cells in basic research.. Stem Cell Reports. 18(9):1744-1752. DOI:10.1016/j.stemcr.2023.08.003.

Pages